Luther King Capital Management (LKCM)
BIIB icon

Luther King Capital Management (LKCM)’s Biogen BIIB Stock Holding History

Luther King Capital Management (LKCM)’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-1,227
Closed -$496K – 539
2015
Q2 		$496K Sell
1,227
-710
-37% -$285K ﹤0.01% 432
2015
Q1 		$818K Sell
1,937
-455
-19% -$179K 0.01% 384
2014
Q4 		$812K Buy
2,392
+992
+71% +$321K 0.01% 391
2014
Q3 		$463K Hold
1,400
– – ﹤0.01% 459
2014
Q2 		$441K Buy
1,400
+710
+103% +$214K ﹤0.01% 458
2014
Q1 		$211K Buy
+690
New +$219K ﹤0.01% 511
2013
Q4 		– Sell
-3,975
Closed -$957K – 523
2013
Q3 		$957K Hold
3,975
– – 0.01% 436
2013
Q2 		$855K Buy
+3,975
New +$849K 0.01% 445

Other funds holding BIIB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return

Luther King Capital Management (LKCM)'s BIIB Position: Q3 2015 in Review

Luther King Capital Management (LKCM) sold out of Biogen (BIIB) in Q3 2015, closing a stake of 1,227 shares — an estimated $496K sold.

Luther King Capital Management (LKCM) first reported a position in BIIB in Q2 2013 and held it in 8 quarters. The position peaked at $957K in Q3 2013. 924 funds tracked by Wall St. Rank hold BIIB as of Q3 2015.

  • Luther King Capital Management (LKCM) reported no remaining Biogen position as of Q3 2015 after selling out during the quarter.
  • Luther King Capital Management (LKCM) sold 1,227 Biogen shares in Q3 2015, an estimated $496K.
  • Luther King Capital Management (LKCM) first reported a position in Biogen in Q2 2013 and held it in 8 quarters.
  • Luther King Capital Management (LKCM)'s Biogen position peaked at $957K in Q3 2013.
  • 924 funds tracked by Wall St. Rank held Biogen as of Q3 2015.

Based on Luther King Capital Management (LKCM)'s 13F filing for Q3 2015, filed 13 Nov 2015.